Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2007 1
2008 1
2009 1
2010 6
2011 9
2012 7
2013 11
2014 9
2015 6
2016 11
2017 11
2018 7
2019 19
2020 24
2021 31
2022 40
2023 36
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus.
Suzuki Y, Kaneko H, Okada A, Itoh H, Matsuoka S, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Kamiya K, Matsunaga A, Ako J, Node K, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: kaneko h. Cardiovasc Diabetol. 2022 May 18;21(1):67. doi: 10.1186/s12933-022-01508-6. Cardiovasc Diabetol. 2022. PMID: 35585590 Free PMC article.
Antihypertensive Drugs and Cancer Risk.
Kidoguchi S, Sugano N, Yokoo T, Kaneko H, Akazawa H, Mukai M, Node K, Yano Y, Nishiyama A. Kidoguchi S, et al. Among authors: kaneko h. Am J Hypertens. 2022 Sep 1;35(9):767-783. doi: 10.1093/ajh/hpac066. Am J Hypertens. 2022. PMID: 35595533 Review.
Future Prospects of Onco-Hypertension.
Minegishi S, Nishiyama A, Yano Y, Node K; JSH Working Group Onco-Hypertension. Minegishi S, et al. Hypertension. 2023 Jul;80(7):e123-e124. doi: 10.1161/HYPERTENSIONAHA.123.21011. Epub 2023 May 11. Hypertension. 2023. PMID: 37315121 No abstract available.
HDL cholesterol and clinical outcomes in diabetes mellitus.
Ishibashi T, Kaneko H, Matsuoka S, Suzuki Y, Ueno K, Ohno R, Okada A, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Yasunaga H, Komuro I. Ishibashi T, et al. Among authors: kaneko h. Eur J Prev Cardiol. 2023 Jun 1;30(8):646-653. doi: 10.1093/eurjpc/zwad029. Eur J Prev Cardiol. 2023. PMID: 36738171
Association of cancer with the risk of developing hypertension.
Nagasawa H, Kaneko H, Suzuki Y, Okada A, Fujiu K, Takeda N, Morita H, Nishiyama A, Yano Y, Node K, Viera AJ, Carey RM, Oparil S, Yasunaga H, Touyz RM, Komuro I. Nagasawa H, et al. Among authors: kaneko h. Eur Heart J Qual Care Clin Outcomes. 2023 Jun 15:qcad036. doi: 10.1093/ehjqcco/qcad036. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 37321962
Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease.
Kaneko H, Yano Y, Okada A, Itoh H, Suzuki Y, Yokota I, Morita K, Fujiu K, Michihata N, Jo T, Yamaguchi S, Takeda N, Morita H, Node K, Yamauchi T, Nangaku M, Kadowaki T, McEvoy JW, Lam CSP, Yasunaga H, Komuro I. Kaneko H, et al. J Am Heart Assoc. 2023 Jan 17;12(2):e027684. doi: 10.1161/JAHA.122.027684. Epub 2023 Jan 11. J Am Heart Assoc. 2023. PMID: 36628975 Free PMC article.
Benign Prostatic Hyperplasia and Incident Cardiovascular Disease.
Suzuki Y, Kaneko H, Okada A, Fujiu K, Jo T, Takeda N, Tanaka A, Node K, Morita H, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: kaneko h. Circ J. 2024 Feb 22;88(3):408-416. doi: 10.1253/circj.CJ-23-0607. Epub 2024 Jan 19. Circ J. 2024. PMID: 38246651 Free article.
Cardiovascular events after the initiation of immune checkpoint inhibitors.
Suzuki Y, Kaneko H, Tamura Y, Okada A, Fujiu K, Michihata N, Takeda N, Jo T, Morita H, Node K, Yasunaga H, Komuro I. Suzuki Y, et al. Among authors: kaneko h. Heliyon. 2023 May 18;9(5):e16373. doi: 10.1016/j.heliyon.2023.e16373. eCollection 2023 May. Heliyon. 2023. PMID: 37251893 Free PMC article.
208 results